Axsome Therapeutics Inc
(MEX:AZSM)
MXN
1519
0 (0%)
Market Cap: 85.66 Bil
Enterprise Value: 83.20 Bil
PE Ratio: 0
PB Ratio: 42.15
GF Score: 39/100 Axsome Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023 / 04:20PM GMT
Release Date Price:
MXN1320
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
All right, everybody. We're going to get going with our next company presenter. Thank you for joining us at the BofA Annual Healthcare Conference. My name is Jason Gerber. I'm one of the biotech analysts, and I'm pleased to be introducing Axsome Therapeutics and Herriot Tabuteau, CEO. So first, Herriot, thanks so much for joining us.
Herriot Tabuteau
Axsome Therapeutics, Inc. - Founder, Chairman, CEO & President
Thanks, Jason, for having us. I think this is the first time that we're presenting at the BofA conference. So...
Questions & Answers
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Maybe virtually in the past. But yes, it's good to have you in person. So a lot going on at the company. You've got some pipeline readouts, some regulatory advancements in the launch that's going on. And maybe just coming out of the quarter, any high-level thoughts or takeaways just in terms of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot